IL17A and rheumatoid arthritis: Metalloproteinases (MMPS), nitric oxide and RANK/RANKL receptor activators, can be upregulated by IL-17 in both cartilage and osteoblasts, leading to damage of bone and articular cartilage and promoting the development of RA (Lundy et al., 2007).